USP has published a “stimuli article” in its Pharmacopeial Forum (PF) proposing revision of the current USP chapter regarding the temperature at which specific pharmaceutical products can be distributed and stored. Current stability studies, the PF article maintains, support significantly widening the range to 2-30º C from 15-25º C or 20-25º C.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
